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Ethnopharmacological relevance: Schinus terebinthifolius is a species of plant from the Anacardiaceae fa-
mily, which can be found in different regions of Brazil. Schinus is popularly known as aroeirinha, aroeira-
vermelha, or Brazilian pepper. In folk medicine, S. terebinthifolius is used for several disorders, including
inﬂammatory conditions, skin wounds, mucosal membrane ulcers, respiratory problems, gout, tumors,
diarrhea and arthritis. According to chemical analyses, gallic acid, methyl gallate and pentagalloylglucose
are the main components of hydroalcoholic extracts from S. terebinthifolius leaves. In the present study,
we demonstrated the ability of a hydroalcoholic extract to inhibit cell migration in arthritis and in-
vestigated the mechanisms underlying this phenomenon.
Materials and methods: The anti-inﬂammatory effect of S. terebinthifolius hydroalcoholic leaf extract (ST-
70) was investigated in a zymosan-induced experimental model of inﬂammation. Male Swiss and C57Bl/
6 mice received zymosan (100 mg/cavity) via intra-thoracic (i.t.) or intra-articular (i.a.) injection after oral
pre-treatment with ST-70. The direct action of ST-70 on neutrophils was evaluated via chemotaxis.
Results: ST-70 exhibited a dose-dependent effect in the pleurisy model. The median effective dose (ED50)
was 100 mg/kg, which inhibited 70% of neutrophil accumulation when compared with the control group.
ST-70 reduced joint diameter and neutrophil inﬂux for synovial tissues at 6 h and 24 h in zymosan-
induced arthritis. Additionally, ST-70 inhibited synovial interleukin (IL)-6, IL-1β, keratinocyte-derived
chemokine (CXCL1/KC) and Tumor Necrosis Factor (TNF)-α production at 6 h and CXCL1/KC and IL-1β
production at 24 h. The direct activity of ST-70 on neutrophils was observed via the impairment of
CXCL1/KC-induced chemotaxis in neutrophils. Oral administration of ST-70 did not induce gastric da-
mage. Daily administration for twenty days did not kill any animals. In contrast, similar administrations
of diclofenac induced gastric damage and killed all animals by the ﬁfth day.
Conclusions: Our results demonstrated signiﬁcant anti-inﬂammatory effects of ST-70, suggesting a pu-
tative use of this herb for the development of phytomedicines to treat inﬂammatory diseases, such as
joint inﬂammation.
& 2015 Elsevier Ireland Ltd. All rights reserved.rved.
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Schinus terebinthifolius Raddi (Anacardiaceae) is a native plant
from South America. It has been used in folk medicine as teas,
infusions or tinctures; as an anti-inﬂammatory, febrifuge, analge-
sic, and depurative agent; and to treat urogenital system illnesses
(Medeiros et al., 2007). Through ethnopharmacological research,
the gastroprotective properties of S. terebinthifolius are remarkably
effective, especially in the treatment of gastritis and ulcers (Carlini
et al., 2010). Previous reports have demonstrated that S. ter-
ebinthifolius extracts or fractions rich in polyphenols, display an-
tioxidant, antibacterial, antifungal and anti-allergic activities in
different experimental models (Cavalher-Machado et al., 2008; de
Lima et al., 2006; Schmourlo et al., 2005; Velázquez et al., 2003).
Despite its importance in popular medicine for the treatment of
inﬂammatory disorders, few scientiﬁc studies have examined the
biological activities and chemical composition of S. terebinthifolius
extracts.
Inﬂammation is a complex physiological response that occurs
in vascularized tissues in response to harmful stimuli, such as
pathogens, damaged cells or irritants. The inﬂammatory process is
coordinated by different chemical mediators that induce vasodi-
lation, plasma leakage and leukocyte margination. However, when
the inﬂammatory response becomes prolonged or chronic, the
same process can become destructive and has been linked to a
number of diseases. Chronic inﬂammation can result from a failure
to eliminate harmful stimuli, an abnormal autoimmune response
or the persistence of a low-intensity irritant that continually
causes acute inﬂammation response (Medzhitov, 2010).
Rheumatoid arthritis (RA) is a chronic autoimmune in-
ﬂammatory disease characterized by pathological changes, such as
persistent synovitis, vascular proliferation, inﬁltration of in-
ﬂammatory cells, and damage to cartilage and bone (Scott et al.,
2010). A critical factor that contributes to joint damage is the ex-
cessive production of inﬂammatory mediators by resident or in-
ﬁltrating inﬂammatory cells. Cytokines (TNF-α and IL-1β) and ei-
cosanoids (leukotrienes and prostaglandins) are involved in the
pathogenesis of arthritis and participate in pain, neutrophil accu-
mulation and tissue damage (Brennan and McInnes, 2008; Guer-
rero et al., 2008). Recently, the importance of IL-17 has been stu-
died in experimental arthritis, wherein the cytokine was detected
during neutrophil accumulation and cartilage degradation and in
hyperalgesic symptoms (Pinto et al., 2010). The recruitment of
neutrophils contributes to the local production of cytokines and
joint damage and appears to be important in the pathogenesis of
human arthritis (Wright et al., 2014). In the last decade, the in-
volvement of other cells, such as macrophages, synoviocytes,
lymphocytes and mast cells, have been described, indicating that a
wider variety of cells are also important in the perpetuating the
articular inﬂammatory process (McInnes and Schett, 2011).
Current clinical treatments for RA include steroidal and non-
steroidal anti-inﬂammatory drugs (SAIDs and NSAIDs, respec-
tively), disease-modifying antirheumatic drugs (DMARDs) and
biological agents (Kalden, 2002). However, the prolonged use of
SAIDS and NSAIDS has been associated with serious adverse ef-
fects, including gastrointestinal disorders, immunodeﬁciency and
humoral disturbances (Roth, 2012), which are factors that have
been attributed to treatment dropout.
In recent decades, the screening of safer and more potent anti-
inﬂammatory drugs for clinical use has increased. In this context,
plants with anti-inﬂammatory activities have shown promising
effects against inﬂammatory diseases, such as arthritis (Lama and
Saikia, 2011). A few reports have shown that a polyphenol from
green tea extract displayed a protective effect in a model of in-
ﬂammatory arthritis, largely through its ability to inhibit the
production of key inﬂammatory mediators, such as IL-1β and IL-6,by RA synovial ﬁbroblasts (Ahmed et al., 2006).
Considering the popular uses of teas and tinctures for medic-
inal purposes, we evaluated the anti-inﬂammatory effect of hy-
droalcoholic extracts from S. terebinthifolius Raddi to assess its
ability to inhibit cell migration and inﬂammatory mediators in
experimental arthritis. Furthermore, we explored the mechanisms
involved in this phenomenon.2. Materials and methods
2.1. Reagents
Zymosan serotype A, dexamethasone, potassium diclofenac,
phosphate buffered saline (PBS), buffer perborate, o-phenylene-
diamine dihydrochloride (OPD), Bradford reagent, bovine serum
albumin (BSA), ethylene diamine tetraacetic acid disodium salt
(EDTA), RPMI 1640 medium and fMLP (N-formyl-methionyl-leu-
cyl-phenylalanine) were all obtained from Sigma Chemical Co. (St.
Louis, MO, USA). DMSO (for biological tests), ethyl ether, ethyl
acetate, n-hexane, dichloromethane, methanol and acetone for
chromatography were purchased from Vetec Química Fina, Ltda.
(Xerém, RJ, Brazil). LTB4 immuno-assay kit was obtained from
Cayman Chemicals (Ann Arbor, Michigan, USA). Puriﬁed anti-
murine TNF-α, CXCL1/KC, IL-6 and IL-1β mAbs; biotinylated anti-
TNF-α, CXCL-1/KC, IL-6 and IL-1β mAbs; and recombinant TNF-α,
CXCL-1/KC, IL-6 and IL-1β were all obtained from R&D Systems
(Minneapolis, MN, USA).
2.2. Preparation and analysis of ST-70 extract
Leaves were collected from 10 individual of S. terebinthifolius
plants in the Atlantic Forest Campus FIOCRUZ, Jacarepaguá, Rio de
Janeiro, RJ, Brazil, and a voucher specimen was deposited into the
Rio de Janeiro Botanical Garden Herbarium under number RB-
451742.
The collected material were dried at 40 °C in an oven with air
circulation, reduced to small fragments and extracted with 70%
ethanol in a dynamic maceration for 24 h. Then, the extract was
ﬁltered, concentrated under reduced pressure and lyophilized,
resulting in a hydroethanolic extract (ST-70) with a yield of 11.00%.
These conditions were based on previous studies of extraction
times.
The ST-70 extract was analyzed using techniques such as ad-
sorption column chromatography, thin layer chromatography,
partition chromatography (countercurrent chromatography), gas
chromatography coupled to mass spectrometry, high performance
liquid chromatography (HPLC) and crystallization by traditional
methodologies.
Several different methodologies were employed to isolate
compounds from S. terebinthifolius. Spectrometric and spectro-
scopic analyses led to the identiﬁcation of luteolin, quercetin,
kaempferol, agathisﬂavone, gallic acid (GA), methyl gallate (MG),
1,2,3,4,6-pentagalloylglucose (PG), epicatechin, α-amyrin, β-amyr-
in, and lupeol.
The main secondary metabolite constituents in the extract,
namely GA and MG, were assigned by HPLC analyses to the re-
spective standard substances based on the similarities of their UV
spectra on a diode array detector (DAD) at 220–400 nm and their
retention times (6.6 min for GA and 15.0 min for MG). The HPLC
chromatograms of ST-70 and the standards are shown in Fig. 1. The
samples and the standard compounds were prepared in methanol
through conventional dilution, and 20 mL was injected for analysis.
A Supelcosil LC-18 column (2504.6 mm2, 5 μm) coupled to a
Supelcosil LC-18 (4.0 mm20 mm, 5 mm) guard-column (Supelco,
Bellefonte) was used. The following gradient program of the
Fig. 1. HPLC-270 nm chromatogram of the hydroalcoholic extract from S. ter-
ebinthifolius leaves. GA, gallic acid. MeG, methyl gallate. PG, 1,2,3,4,6-penta-
galloylglucose. PP, other gallic acid derivatives.
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pH 2.5 (A) and methanol/acetonitrile 1:3 v/v (B), was performed at
40 °C and 1.0 ml/min: 0–20 min, 3–20% B; 20–30 min, 20–30% B;
30–35 min, 30–50% B; 35–40 min, 50–96% B; 40–45 min, 96-3% B;
and 45–60 min, 3% B. Detection was set at 270 nm. Separately, the
extract was spiked with the standards to conﬁrm peak assign-
ments. The GA and MG contents of ST-70 were determined
based on calibration curves of the standards, which were
tested in triplicate to conﬁrm linearity and validity via
ANOVA. The range (18.1–226 mg/ml for GA and 2.0–200 mg/ml for
MG), linearity [yGA¼14.24103 (mg GA/ml) at r¼0.9998,
yMG¼12.52103 (mg MG/ml) at r¼0.9997], precision (relative
standard deviation for GA¼2.02 and for MG¼2.07) and limits of
quantiﬁcation (1 and 0.2 mg/ml for GA and MG, respectively) were
determined following the International Conference of Harmoni-
zation guidelines (ICH, 2005) and literature recommendations
(Ribani et al., 2004). The extract was composed of 13.770.3 mg/g
of GA and 2.370.1 mg/g of MG. A total of 17272.1 mg/g of eight
main polyphenolic components presented UV spectra similar to
that of GA, including 1,2,3,4,6-pentagalloylglucose (PG at
37.470.9 mg/g), were estimated by an external calibration versus
an MG curve.
2.3. Animals
Male Swiss-44 and C57BL/6 mice (20–30 g) from CECAL-FIO-
CRUZ bioterium were maintained on a 12 h-light/dark cycle with
controlled temperature and free access to food and fresh water. All
experiments were conducted under license number CEUA LW-43/
14 in accordance with the ethical guidelines of the International
Association for the Study of Pain and the institutional guidelines
for animal use.
2.4. Treatments
Mice that were fasted overnight received ST-70 (3.125–200 mg/
kg) orally (p.o.) in a ﬁnal volume of 200 μl 1 h prior to stimulation.
As reference drugs, dexamethasone (10 mg/kg, 100 μl) was ad-
ministered i.p., and potassium diclofenac (100 mg/kg, 200 μl) was
administered p.o. 1 h prior to stimulation. Equivalent volumes of
vehicle were administered to the control groups.
2.5. Zymosan-induced pleurisy
Swiss mice were orally pre-treated with diclofenac (100 mg/kg)
or different doses of extract (3,125–200 mg/kg) 1 h before zymo-
san-induced pleurisy in order to determine the ST-70 effective
dose to reduce inﬂammation by half (ED50). The control groupreceived an i.t. injection of an equal volume of vehicle. The animals
were euthanized 4 h after stimulus by carbon dioxide (CO2) in-
halation, and their thoracic cavities were washed with 1 ml of PBS
containing EDTA (10 mM) at pH 7.4. Total leukocyte counts were
performed on all washes from thoracic cavities using an automatic
particle counter (Coulter Z2, Beckman Coulter Inc., Brea, CA, USA).
Differential cell counts were performed under light microscopy
(1000 ) using cytospin smears (Cytospin 3, Shandon Inc., Pitts-
burgh, PA, USA) stained according to the May–Grunwald–Giemsa
method. The counts were reported as the numbers of cells (106)
per cavity. Then, pleural washes were centrifuged at 400 g for
10 min. Supernatants were stored at 80 °C for further EIA and
ELISA. The total protein contents of, the supernatants were quan-
tiﬁed using the Bradford method according to the manufacturer's
instructions.
2.6. Experimental arthritis
Joint inﬂammation was induced by intra-articular (i.a.) injec-
tion of zymosan (500 μg/cavity) that was diluted in sterile saline to
a ﬁnal volume of 25 μl, according to the technique of Conte et al.
(2008). Control animals (C57BL/6 mice) received i.a. injections of
equal volumes of sterile saline. Knee-joint swelling was evaluated
by measuring the transverse diameters of each knee joint using
digital calipers (Digmatic Caliper, Mitutoyo Corporation, Kanaga-
wa, Japan). Animals were pre-treated 1 h prior with ST-70
(100 mg/kg) or dexamethasone. Values of knee joint thickness
were expressed in millimeters (mm) as the difference of the knee-
joint diameter before and after the induction of articular in-
ﬂammation (Δ). After 6 h or 24 h of joint inﬂammation induction,
the mice were euthanized by carbon dioxide inhalation. Knee sy-
novial cavities were washed with 300 μl of PBS containing EDTA
(10 mM). Total leukocyte counts were performed in an automatic
particle counter (Coulter Z2, Beckman Coulter Inc., Brea, CA, USA).
Differential cell counts were performed under light microscopy
(1000 ) using cytospin smears (Cytospin 3, Shandon Inc., Pitts-
burgh, PA, USA) stained according to the May–Grunwald–Giemsa
method. The counts were reported as numbers of cells per cavity
(105). The synovial washes were centrifuged at 400 g for
10 min and stored at 80 °C for further analyses.
2.7. Enzyme-linked immunosorbent assay (ELISA)
Levels of the CXCL1/KC and IL-6 were evaluated in Swiss mice
pleural washes. CXCL1/KC, IL-6, TNF-α and IL-1β levels were
quantiﬁed in C57BL/6 mice synovial washes by sandwich ELISA
using matched antibody pairs from R&D Systems (Quantikine.
Minneapolis, MN, USA) according to the manufacturer's
instructions.
2.8. Determination of cytotoxicity
To investigate the treatment of GA on cellular viability, J774A.1.
cells were plated onto black, ﬂat-bottomed 96-well plates at a
density of 2.5106 cells/well. After 1 h of incubation in a con-
trolled atmosphere (5% CO2, 37 °C), the cells received fresh med-
ium with or without Tween 20 (3%), DMSO (0.5%) and GA (1, 10 or
100 nM) in a quadruplicate assay. After 21 h of further incubation,
20 mL of an Alamar Blue solution were added to each well. After an
additional 3 h, the ﬂuorescence was read on a SpectraMax M5/
M5e microplate reader (Molecular Devices; kexc 555 nm, kem
585 nm).
2.9. Murine neutrophil puriﬁcation
C57BL/6 mice were euthanized, and the femurs from both hind
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The distal tip of the femur extremity was excised, and each femur
was washed with 2 ml of Ca2þ/Mg2þ-free HBSS–EDTA solution.
Cell suspensions were then centrifuged at 400 g for 15 min at
20 °C and resuspended in 2 ml Ca2þ/Mg2þ-free HBSS–EDTA. The
cells were puriﬁed via Percoll discontinuous gradient centrifuga-
tion (65% and 72% diluted in Ca2þ/Mg2þ-free HBSS–EDTA). Brieﬂy,
the cells were centrifuged at 1200 g for 35 min at room tem-
perature without braking, and polymorphonuclear cells were re-
covered from the 65%/72% interface. Then, neutrophils were
counted in a Neubauer chamber, identiﬁed by cytospin cen-
trifugation, and followed by Wright-Giemsa coloration according
to the manufacturer's instructions.
2.10. Human neutrophil puriﬁcation
Human neutrophils were isolated from citrate (3.8%)-treated
peripheral venous blood of healthy volunteers using a four-step
discontinuous Percoll gradient (Amersham Biosciences, San Fran-
cisco, CA, USA). Erythrocytes were removed by hypotonic lysis.
Isolated neutrophils (98% purity), estimated to be 496% viable by
Trypan blue exclusion, were resuspended in RPMI 1640 medium.
2.11. Chemotaxis assay
Neutrophil chemotaxis was assayed in a 48-well Boyden
chamber (Neuroprobe, Inc. Cabin John, MD, USA) using a 5-mm
PVP-free polycarbonate ﬁlter (Nuclepore, Pleasanton, CA, USA).
Brieﬂy, puriﬁed murine neutrophils were incubated with ST-70
(500 mg/ml) or dexamethasone (50 nM) for 1 h prior to the che-
motaxis assay. Then, the cells were centrifuged at 400 g for
10 min at room temperature and assayed in a chemotaxis cham-
ber. The bottom wells of the chamber were ﬁlled with 29 ml of a
chemoattractant stimulant, CXCL-1/KC (250 nM). Pre-treated
neutrophils (1105 cells/50 ml) were seeded in the upper com-
partment. The chamber was then incubated at 37 °C in 5% CO2
atmosphere for 1 h, and the ﬁlter was ﬁxed and stained by Wright-
Giemsa coloration according to the manufacturer's instructions. In
another set of assays, puriﬁed human neutrophils were incubated
with one of the main polyphenols of ST-70, GA (100 nM), or dex-
amethasone (50 nM) for 1 h prior to the chemotaxis assay. Then,
the human cells were assayed in chemotaxis chambers, as de-
scribed above, under fMLP (10 mM) stimulation. Neutrophils that
had migrated through the membrane were counted under a light
microscope (1000magniﬁcation) in 15 random ﬁelds. The result
is expressed as the mean number of migrated neutrophils per
ﬁfteen ﬁelds.
2.12. Ulcerogenic activity and survival
Swiss mice that were fasted for 24 h were orally administered
either different doses of ST-70 (100 or 400 mg/kg) or potassium
diclofenac (100 mg/kg) diluted in ﬁltered water to a ﬁnal volume
of 200 ml. After 5 h, the mice were euthanized. The stomachs were
removed, opened along the greater curvature and gently washed
with PBS. Gastric lesions were analyzed under a stereoscopic mi-
croscope (Olympus, Japan) by a single-blind method. Additionally,
Swiss mice received daily p.o. ST-70 (100 mg/kg), potassium di-
clofenac (100 mg/kg) diluted in ﬁltered water to a ﬁnal volume of
200 ml, or only ﬁltered water (200 ml) for twenty days to assess
survival rates.
2.13. Statistical analysis
All results are expressed as the means7standard errors of the
means (SEM) and were evaluated using one-way ANOVA followedby the Student–Newman–Keuls test. A log-rank (Mantel–Cox) test
was used to compare the survival rates. The signiﬁcance level was
set at Pr0.05.3. Results
3.1. ST-70 inhibits leukocyte inﬁltration and inﬂammatory mediator
production in pleurisy
To determine the dose-response effect of ST70, it was applied
to zymosan-induced pleurisy. As shown in Fig. 2A and B, the oral
pre-treatment with different doses of ST-70 (3.125–200 mg/kg)
signiﬁcantly inhibited (from 25 mg/kg) the migration into pleural
sites of total leukocytes, including neutrophils, 4 h after stimula-
tion in a dose-dependent manner. According to the dose–response
curve for leukocyte inﬁltration, the ED50 of ST-70 was 100 mg/kg
(Fig. 2C). Potassium diclofenac, a nonsteroidal anti-inﬂammatory
drug (NSAID), was used as a reference inhibitor. As was observed
with 100 mg/kg ST-70, the oral pre-treatment with 100 mg/kg
diclofenac similarly inhibited total leukocyte and neutrophil ac-
cumulation (Fig. S1).
The migration and activation of neutrophils during inﬂamma-
tion results from several events, such as cytokine and chemokine
action. In zymosan pleural washes, increased CXCL-1/KC and IL-6
levels were detected when compared with control groups. The oral
pre-treatment with ST-70 (100 mg/kg) decreased the concentra-
tions of CXCL-1/KC and IL-6 by 99.92% and 96.52%, respectively
(Fig. 2D). A smaller decrease was observed after potassium diclo-
fenac (100 mg/kg) pre-treatment (Fig. 2D).
3.2. ST-70 inhibits neutrophils migration on zymosan-induced
arthritis
We previously reported that the i.a. injection of zymosan
(500 μg/cavity) induced an articular inﬂammatory response after
6 h, which was characterized by a signiﬁcant increase in edema
formation and massive neutrophil inﬂux peaking at 24 h (Conte
et al., 2008; Penido et al., 2006). In the present study, the analyses
were performed at 6 h and 24 h after stimulation because marked
inﬂammatory reactions were already observed at these time
points (Figs. 3 and 4). As shown in Fig. 3A and E, the oral pre-
treatment with ST-70 (100 mg/kg) 1 h prior to zymosan injection
markedly reduced knee-joint thickness at 6 h and 24 h after sti-
mulation. Notably, the oral treatment with ST-70 induced a similar
effect as that achieved via the i.p. administration of dex-
amethasone (10 mg/kg) (Fig. 3A and E). The treatments with ST-70
or dexamethasone also inhibited total leukocyte, mononuclear cell
and neutrophil inﬁltration when compared with non-treated mice
6 h after i.a. zymosan injection (Fig. 3B–D). However, 24 h after
stimulation, the ST-70 pre-treatment inhibited total leukocyte and
neutrophil migration but failed to reduce mononuclear cell inﬂux
into the synovial cavity (Fig. 3F–H). Interestingly, a single oral
treatment with ST-70 (100 mg/kg) was able to inhibit edema for-
mation and leukocyte migration at all times analyzed after i.a.
zymosan injection. It is noteworthy that ST-70 also inhibited
murine neutrophil chemotaxis induced by CXCL-1/KC in vitro,
demonstrating a direct effect of ST-70 on neutrophils (Fig. S2).
3.3. ST-70 reduces pro-inﬂammatory mediators in articular zymo-
san-injected knee joints
To investigate whether ST-70 exerted its anti-inﬂammatory
effect by modulating the production of inﬂammatory mediators,
we analyzed its effect on the production of CXCL-1/KC, IL-6, TNF-α
and IL-1β. As demonstrated in Fig. 4A–H, the articular cavity levels
Fig. 2. Study of the dose–response effect of the hydroalcoholic extract from S. terebinthifolius (ST-70) on cell migration and the production of inﬂammatory mediators. Effect
of pre-treatment with ST-70 (3.125–200 mg/kg, p.o., 1 h before stimulation) on (A) total leukocyte and (B) neutrophil recruitment were analyzed 4 h after zymosan i.t.
injection (100 mg/cavity; black columns). Control animals received saline i.t. injection (100 ml/cavity; white columns). (C) Dose–response log-curve of ST-70 treatment based
on neutrophil recruitment analysis; the ED50 was calculated as 100 mg/kg. (D) CXCL-1/KC and IL-6 production from thoracic cavity washes were measured by ELISA. Data are
presented as the means7SEM (n¼6). Signiﬁcant differences (Po0.05) are indicated between stimulated and non-stimulated groups (*) and between treated and non-
treated groups (þ).
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after i.a. zymosan injection. ST-70 oral pre-treatment markedly
reduced zymosan-induced CXCL-1/KC, IL-6, TNF-α, and IL-1β pro-
duction 6 h after i.a. injection (Fig. 4A–D). ST-70 (100 mg/kg) only
signiﬁcantly inhibited CXCL-1/KC and IL-1β production 24 h after i.
a. zymosan injection (Fig. 4E and H). Pre-treatment with dex-
amethasone reduced the production of CXCL-1/KC, IL-6, TNF-α and
IL-1β at both time points investigated.
3.4. Gallic acid from ST-70 exhibits anti-inﬂammatory activity
Phytochemical studies revealed that GA is one of the major
polyphenol components of the ST-70 extract. To determine whe-
ther this substance is responsible for the observed effect on neu-
trophil migration, we evaluated the effect of GA on human neu-
trophil chemotaxis. First, the effect of GA (1, 10 and 100 nM) wasassessed on cell viability using the resazurin assay; none of tested
concentrations were cytotoxic (100 nM Z95% viability). Pre-
treatment with GA (100 nM) signiﬁcantly reduced neutrophil
chemotaxis (Fig. 5). This result suggests that GA is one of the
bioactive component present in ST-70 extracts.
3.5. ST-70 does not induce gastric injury or death in mice
As shown in Fig. 6, animals that received a single oral dose of
sodium diclofenac (100 mg/kg) showed high indices of gastric le-
sions (Fig. 6A) but did not exhibit decreased mucus secretions
(Fig. 6B). Furthermore, 100% of the mice died up to the ﬁfth day
after daily sodium diclofenac oral administration (Fig. 6C). How-
ever, ST-70 oral administration (100 or 400 mg/kg) induced few
gastric lesions when compared with the control group (non-trea-
ted animals) and did not decrease the production of mucus
Fig. 3. ST-70 effect on edema and leukocyte migration during zymosan-induced arthritis. Knee-joint diameter was measured with a digital caliper, and knee synovial cells
were recovered 6 h or 24 h after zymosan stimulation. Pre-treatment with ST-70 (100 mg/kg, p.o., 1 h before stimulation) was analyzed in (A) knee-joint thickness, (B) total
leukocyte, (C) neutrophil and (D) mononuclear cell migration 6 h after zymosan i.a. injection (500 mg/25 ml/cavity; black columns) and in (E) knee-joint thickness, (F) total
leukocyte, (G) neutrophil and (H) mononuclear cells migration 24 h after zymosan i.a. injection (500 mg/25 ml/cavity; black columns). Control animals received sterile saline i.
a. injection (25 ml/cavity; white columns). Dexamethasone (Dexa, 100 mg/kg) was applied i.p. 1 h before stimulation. Data are presented as the means7SEM (n¼7). Sig-
niﬁcant differences (Po0.05) are indicated between stimulated and non-stimulated groups (*) and between treated and non-treated groups (þ).
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received a 400 mg/kg dose displayed increased gastric mucus
production. Additionally, the mice that were orally administered
ST-70 daily for twenty days remained alive at the end of the ex-
periment (Fig. 6C), showing no acute toxicity.4. Discussion
In the present work, we showed that the hydroalcoholic extract
from S. terebinthifolius Raddi leaves (ST-70) exhibited important
anti-inﬂammatory properties in pleurisy and arthritis, including a
marked inhibition of neutrophil inﬂux and reduced inﬂammatory
mediators induced by zymosan. Previous results from our group
demonstrated an anti-allergic effect of the ethyl acetate fraction
from S. terebinthifolius leaves (ST fraction), in which HPLC analysis
identiﬁed gallic acid, methyl gallate and 1,2,3,4,6-penta-
galloylglucose as polyphenol components of ST fraction (Cavalher-
Machado et al., 2008). In this work, the ST-fraction was shown to
reduce eosinophil migration in allergic pleurisy. To date, the effect
of S. terebinthifolius on experimental arthritis and neutrophil mi-
gration in acute inﬂammatory responses has not been studied.
Natural products have been tested in a wide range of in-
ﬂammatory models, including zymosan-induced pleurisy (Penido
et al., 2006). In fact, during zymosan-induced inﬂammatory re-
sponses, it is possible to study the mechanisms of phagocytosis,
cell migration and the production of inﬂammatory mediators
(Underhill, 2003). Herein, we performed a dose–response analysis
using zymosan-induced pleurisy to pharmacologically investigate
the link between ST-70 levels and its effect on inﬂammatory
processes. The ED50 of ST-70 in the reduction of leukocyteinﬁltration into the thoracic cavity was calculated to be 100 mg/kg.
Inﬂammatory signaling in response to zymosan requires nu-
clear factor (NF)-κB activation. NF-κB is a pivotal regulator in the
expression of many pro-inﬂammatory cytokines, including TNF-α,
IL-1β, and IL-6, and chemokines, e.g., CXCL-1/KC (Underhill, 2003),
detected at early time points in murine models of inﬂammation
(Ajuebor et al., 1999). Previous reports have shown that TNF-α, IL-
1, IL-6, and CINC (a member of the α-CXC chemokine family in rats)
were sequentially produced during the early stages of zymosan-
induced pleurisy in rats (Utsunomiya et al., 1998). Our results
observed the production of IL-6 and CXCL-1/KC 4 h after zymosan
intra-thoracic injection in mice. Oral pre-treatments with ST-70
(100 mg/kg) inhibited these pro-inﬂammatory mediators by more
than 70%. Thus, our results suggest that ST-70 reduces neutrophil
migration by affecting cytokine and chemokine production.
RA is a disease characterized by neutrophil accumulation. Ele-
vated numbers of neutrophils are found in the synovial ﬂuid of
patients with RA. These activated neutrophils secrete proteases
that contribute to the destruction of cartilage and related joint
structures (Wright et al., 2014). Zymosan-induced arthritis has
been used as an experimental model to assess the anti-in-
ﬂammatory effects of different compounds (Gegout et al., 1995). At
early time points following zymosan i.a. stimulation, edema for-
mation was accompanied by massive neutrophil inﬁltration into
the synovial tissue and the ﬂuids of inﬂamed joints (Conte et al.,
2008). Previous reports demonstrated that zymosan i.a. injection
in rodents is characterized by a marked increase in knee-joint
thickness within 6 h and peaks within 24 h, remaining sig-
niﬁcantly above control values for 20 days (Penido et al., 2006).
Accordingly, we observed that zymosan i.a. injections in mice re-
sulted in a marked increase in knee-joint thickness within 6 h and
Fig. 4. Effect of ST-70 on the production of inﬂammatory mediators 6 and 24 h after zymosan-induced arthritis. Pre-treatment with ST-70 (100 mg/kg, p.o., 1 h before
stimulation) was analyzed in synovial cavity washes collected 6 h or 24 h after zymosan i.a. injection (500 mg/25 ml/cavity; black columns), and (A and E) CXCL-1/KC, (B and F)
IL-6, (C and G) TNF-α and (D and H) IL-1β were measured by ELISA. Dexamethasone (Dexa, 100 mg/kg) was applied i.p. 1 h before stimulation. Data are presented as the
means7SEM (n¼7). Signiﬁcant differences (Po0.05) are indicated between stimulated and non-stimulated groups (*) and between treated and non-treated groups (þ).
Fig. 5. Effect of gallic acid (GA) on human neutrophil chemotaxis. Peripheral hu-
man neutrophils were isolated and subjected to Boyden chamber chemotaxis as-
says in response to fMLP stimulation (10 mM; black column). The cells were pre-
incubated for 1 h with RPMI (control), dexamethasone (50 nM) or GA (100 nM)
before stimulation. Data are presented as the means7SEM (n¼4). Signiﬁcant
differences (Po0.05) are indicated between stimulated and non-stimulated groups
(*) and between treated and non-treated groups (þ).
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This phenomenon was inhibited by ST-70 oral pre-treatment at a
dose of 100 mg/kg. However, the mechanism of action of ST-70 in
the inhibition of zymosan-induced knee-joint edema remains
unknown.Neutrophils are predominant in the synovial exudates of a
variety of inﬂammatory arthropathies, including rheumatoid ar-
thritis; the participation of these cells in the pathogenesis of tissue
lesions has long been recognized (Harris, 1991). However, neu-
trophils do not seem to be responsible for the perpetuation of
chronic synovitis. Neutrophils promote cartilage breakdown and
bone resorption by producing important chemicals, such as re-
active oxygen and nitrogen species, lysosomal enzymes and me-
talloproteases (Hampton et al., 1998). Therefore, strategies to limit
neutrophil trafﬁcking or activation have received attention as po-
tential alternatives to treat arthritis. In the present study, neu-
trophil inﬂux at 6 h and 24 h after zymosan injection was reduced
by a single oral dose of ST-70, as observed in synovial washes.
Thus, the inhibition of neutrophil migration into the synovial
cavity reduced the production of inﬂammatory mediators and,
consequently, tissue damage.
Currently, TNF-α is believed to be the primary mediator in the
inﬂammatory cytokine cascade and in the pathogenesis of RA.
TNF-α is primarily produced by activated macrophages in inﬂamed
synovial membrane tissue and induces the production of other
pro-inﬂammatory cytokines, such as IL-1β and IL-6, and chemo-
kines, such as CXCL-1, leading to the destruction of articular car-
tilage (Brennan and McInnes, 2008; van den Berg et al., 1999).
IL-1β and TNF-α induce neutrophil inﬁltration when injected
into the joints of normal animals. The combination of these cy-
tokines exhibits synergistic activity (Henderson and Pettipher,
1989). A considerable number of studies have shown that block-
ades of IL-1β and TNF-α reduce inﬂammation and joint destruction
in arthritic animal models (Maini and Taylor, 2000). In clinical
studies, antagonism of IL-1β and TNF-α inhibition reduces joint
destruction and the signs and symptoms of RA (Bendele et al.,
2000). We observed that the i.a. injection of zymosan induced high
levels of TNF-α and IL-1β production 6 h and 24 h after
Fig. 6. Effect of ST-70 on mice gastric mucosa and survival. Animals received oral administration of ST-70 (100 or 400 mg/kg, 1 h before stimulation), potassium diclofenac
(100 mg/kg) or water (200 ml). (A) Gastric lesion index and (B) mucus production in gastric mucosa were analyzed 5 h after oral administration. (C) Survival rates for animals
that received daily water (solid line), ST-70 (100 mg/kg; ○) or potassium diclofenac (100 mg/kg; ●). The log-rank test revealed differences in the survival curves between ST-
70 and potassium diclofenac oral administration. Data are presented as the means7SEM (n¼10). Signiﬁcant differences (Po0.05) are indicated between animals that
received diclofenac and non-treated animals (*).
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duction of these cytokines at 6 h post-stimulus; only IL-1β pro-
duction was inhibited 24 h after i.a. zymosan injection.
IL-6 displays pleiotropic effects, including effects on the ma-
turation and activation of macrophages, osteoclasts, chondrocytes
and endothelial cells. The critical role of IL-6 in the pathogenesis of
RA has been demonstrated in clinical trials wherein a speciﬁc anti-
IL-6 antibody was able to suppress the progression of joint erosion
in RA (Brennan and McInnes, 2008). The oral pre-treatment with
ST-70 resulted in a signiﬁcant decrease in IL-6 in the ﬁrst 6 h after
zymosan-induced joint inﬂammation. In our model, the reduction
in IL-6 in the early stages of arthritis seems to be associated with a
reduction in edema and cell migration.
The chemokine CXCL-1/KC binds the CXCR1 and CXCR2 re-
ceptors, which signal through G-proteins. CXCR2 and CXCR1 sig-
naling plays key roles in neutrophil function, especially in che-
motaxis, degranulation, phagocytosis and oxidative burst (Boppa-
na et al., 2014). In our RA experimental model, we observed high
levels of CXCL1/KC production and a reduction in the levels of this
chemokine after oral pre-treatment with ST-70. Furthermore,
neutrophils stimulated with CXCL-1/KC migrated in smaller
quantities when pre-incubated with ST-70. Our data suggest that
the inhibition in neutrophil tissue accumulation in the joint cavity
may be related to impaired CXCL1/KC generation during zymosan-
induced arthritis. Here, we report for the ﬁrst time a direct in-
hibition of neutrophil migration in arthritis by a hydroalcoholic
extract from S. terebinthifolius leaves.
According to previous studies, plant-derived compounds that
can modulate the expression of pro-inﬂammatory signals, such as
polyphenols, may have anti-arthritic potential (Khanna et al.,
2007). In the present report, the phytochemical analyses of ST-70
revealed the presence of the major polyphenols, GA, methyl gallate
and 1,2,3,4,6-pentagalloylglucose. The anti-inﬂammatory effects of
GA have been demonstrated in a few pharmacological studies
(Kang et al., 2009). Recently, the mRNA expression levels of pro-
inﬂammatory cytokines (IL-1β and IL-6), chemokines (CCL-2/MCP-
1 and CCL-7/MCP-3), cyclooxygenase-2, and matrix metallopro-
teinase-9 by ﬁbroblast-like synoviocytes (FLS) from patients with
RA were shown to be suppressed by GA treatment in a dose-de-
pendent manner (Yoon et al., 2013). Therefore, we evaluated theeffect of GA from ST-70 on human neutrophil migration to de-
termine (1) whether GA was responsible for the inhibitory action
of ST-70 in neutrophil migration and (2) whether this compound
was active against human neutrophils. Indeed, the signiﬁcant re-
duction of human neutrophil chemotaxis upon pre-incubation
with non-cytotoxic GA concentrations and stimulation with fMLP
suggests that GA was at least partly responsible for the anti-in-
ﬂammatory effects of ST-70.
The present study is the ﬁrst to report an anti-inﬂammatory
role for the hydroalcoholic extracts of S. terebinthifolius leaves (ST-
70). The long-term oral administration of ST-70 did not induce
lethality and gastric damage, in contrast to mice that received
potassium diclofenac. This suggests that such an extract could be
used to treat inﬂammatory conditions like arthritis. Plant-derived
compounds have been historically valued as a source of anti-in-
ﬂammatory agents (Calixto et al., 2004) with well-documented
therapeutic efﬁcacy and fewer side effects. Hence, the search for
new anti-inﬂammatory drugs from herbal derivatives is justiﬁed.5. Conclusion
Taken together, our results demonstrated that ST-70 inhibited
leukocyte (primarily neutrophils) migration, cytokine and che-
mokine production in inﬂammatory models such as zymosan-in-
duced arthritis. For these reasons, ST-70 may have potential as a
phytomedicine for the treatment of inﬂammatory conditions.Conﬂicts of interest
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